Unknown

Dataset Information

0

Allosteres to regulate neurotransmitter sulfonation.


ABSTRACT: Catecholamine neurotransmitter levels in the synapses of the brain shape human disposition-cognitive flexibility, aggression, depression, and reward seeking-and manipulating these levels is a major objective of the pharmaceutical industry. Certain neurotransmitters are extensively sulfonated and inactivated by human sulfotransferase 1A3 (SULT1A3). To our knowledge, sulfonation as a therapeutic means of regulating transmitter activity has not been explored. Here, we describe the discovery of a SULT1A3 allosteric site that can be used to inhibit the enzyme. The structure of the new site is determined using spin-label-triangulation NMR. The site forms a cleft at the edge of a conserved ?30-residue active-site cap that must open and close during the catalytic cycle. Allosteres anchor into the site via ?-stacking interactions with two residues that sandwich the planar core of the allostere and inhibit the enzyme through cap-stabilizing interactions with substituents attached to the core. Changes in cap free energy were calculated ab initio as a function of core substituents and used to design and synthesize a series of inhibitors intended to progressively stabilize the cap and slow turnover. The inhibitors bound tightly (34 nm to 7.4 ?m) and exhibited progressive inhibition. The cap-stabilizing effects of the inhibitors were experimentally determined and agreed remarkably well with the theoretical predictions. These studies establish a reliable heuristic for the design of SULT1A3 allosteric inhibitors and demonstrate that the free-energy changes of a small, dynamic loop that is critical for SULT substrate selection and turnover can be calculated accurately.

SUBMITTER: Darrah K 

PROVIDER: S-EPMC6378965 | biostudies-literature | 2019 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

Allosteres to regulate neurotransmitter sulfonation.

Darrah Kristie K   Wang Ting T   Cook Ian I   Cacace Mary M   Deiters Alexander A   Leyh Thomas S TS  

The Journal of biological chemistry 20181213 7


Catecholamine neurotransmitter levels in the synapses of the brain shape human disposition-cognitive flexibility, aggression, depression, and reward seeking-and manipulating these levels is a major objective of the pharmaceutical industry. Certain neurotransmitters are extensively sulfonated and inactivated by human sulfotransferase 1A3 (SULT1A3). To our knowledge, sulfonation as a therapeutic means of regulating transmitter activity has not been explored. Here, we describe the discovery of a SU  ...[more]

Similar Datasets

| S-EPMC5502633 | biostudies-literature
| S-EPMC7948405 | biostudies-literature
| S-EPMC2913707 | biostudies-literature
| S-EPMC4894543 | biostudies-literature
| S-EPMC2910808 | biostudies-literature
| S-EPMC7035618 | biostudies-literature
| S-EPMC9803678 | biostudies-literature
| S-EPMC5554727 | biostudies-literature
| S-EPMC8057820 | biostudies-literature
| S-EPMC2000543 | biostudies-literature